Vistagen Therapeutics, Inc. Common Stock
VTGN Real Time Price USDRecent trades of VTGN by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by VTGN's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Dosage forms and therapeutic uses of l-4-chlorokynurenine Jul. 16, 2024
-
Patent Title: Synthesis of 4-chlorokynurenines and intermediates Aug. 30, 2022
-
Patent Title: Dosage forms and therapeutic uses of l-4-chlorokynurenine Apr. 20, 2021
-
Patent Title: Dosage forms and therapeutic uses of l-4-chlorokynurenine Nov. 03, 2020
-
Patent Title: Methods for the synthesis of chiral kynurenine compounds May. 21, 2019
-
Patent Title: Dosage forms and therapeutic uses l-4-chlorokynurenine Jun. 12, 2018
-
Patent Title: Dosage forms and therapeutic uses of l-4-chlorokynurenine Jun. 12, 2018
-
Patent Title: Methods for the synthesis of chiral kynurenine compounds Dec. 05, 2017
-
Patent Title: Toxicity typing using liver stem cells Aug. 20, 2013
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of VTGN in WallStreetBets Daily Discussion
Recent insights relating to VTGN
Recent picks made for VTGN stock on CNBC
ETFs with the largest estimated holdings in VTGN
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view VTGN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.